Track market-moving stories before they get noisy

20.7.2026 08:13

Německo:

08:00 PPI (m-m) (červen): očekávání trhu: -0,3 %, předchozí hodnota: 0,3 %

08:00 PPI (y-y) (červen): očekávání trhu: 1,8 %, předchozí hodnota: 2,2 %

Eurozóna:

11:00 Stavební výroba (m-m) (květen): očekávání trhu: --, předchozí hodnota: 0,6 %

11:00 Stavební výroba (y-y) (květen): očekávání trhu: --, předchozí hodnota: 0,9 %

USA:

16:00 Index předstihových ukazatelů (červen): očekávání trhu: -0,1 %, předchozí hodnota: 0,1 %

Zdroj: Bloomberg

Michal Šnobl
Fio banka, a.s.
Prohlášení

New York, New York--(Newsfile Corp. - July 19, 2026) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Futu Holdings Limited (NASDAQ: FUTU) between May 24, 2023 and May 27, 2026, inclusive (the "Class Period"), of the important August 25, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Futu securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Futu class action, go to https://rosenlegal.com/cases/futu-holdings-limited/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 25, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) Futu was not in compliance with the requirements of the China Securities Regulatory Commission (the "CSRC"), including because Futu continued to conduct securities business, public fund sales business and futures business in mainland China without obtaining the requisite licenses or approval; (2) as a result, Futu was reasonably likely to face regulatory penalties, including the disgorgement of ill-gotten gains and other penalties; (3) as a result of the foregoing, Futu's financial results were overstated; and (4) as a result of the foregoing, defendants' positive statements about Futu's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Futu class action, go to https://rosenlegal.com/cases/futu-holdings-limited/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305747

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Apple (AAPL +0.26%) is likely to report critical information that investors will not want to miss.

*Stock prices used were the afternoon prices of July 16, 2026. The video was published on July 18, 2026.

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Apple. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

NEW YORK, July 19, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Microsoft Corporation (NASDAQ: MSFT) between May 1, 2025 and January 28, 2026, inclusive (the “Class Period”), of the important August 11, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Microsoft common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Microsoft class action, go to https://rosenlegal.com/cases/microsoft-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 11, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Microsoft’s Copilot family of products had experienced significant brand positioning, user experience, usage, data siloing, computational capacity, organizational, and interoperability problems; (2) Microsoft’s flagship proprietary AI model ranked well below competitors on a number of benchmark tests; (3) Microsoft needed to increase by billions of dollars its capital expenditures and divert graphics processing unit (“GPU”) and central processing unit (“CPU”) capacity away from fulfilling demand for its profitable Azure services in order to improve the competitive positioning of its critical Copilot family of products and increase its AI-related research and development (“R&D”); and (4) as a result, Microsoft had failed to convert a significant percentage of its commercial Microsoft 365 users to paid Copilot subscriptions and Microsoft’s Copilot offerings had lost market share to rival products, a trend that was increasing. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Microsoft class action, go to https://rosenlegal.com/cases/microsoft-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Attendees talk at the Farnborough International Airshow, in Farnborough, Britain, July 22, 2024. REUTERS/Toby Melville/File Photo Purchase Licensing Rights, opens new tab

SummaryCompaniesAirbus and Boeing could secure around 300 aircraft orders, sources told ReutersDefence companies will account for half of the show's record 1,600 exhibitorsIncoming British PM Burnham may appear at July ​20 to 24 AirshowFARNBOROUGH, England, July 20 (Reuters) - Farnborough Airshow ‌opens on Monday with Boeing (BA.N), opens new tab and Airbus (AIR.PA), opens new tab pursuing aircraft deals and defence firms vying for a share of booming military budgets fuelled by wars in Ukraine and the Middle East.

Planemakers are expected to announce a string of deals ​during the week, although industry sources say total orders are likely to fall well ​short of some analyst forecasts of 800 aircraft or more, reflecting supply-chain ⁠constraints that continue to limit production.

The Reuters Iran Briefing newsletter keeps you informed with the latest developments and analysis of the Iran war. Sign up here.

At the same time, defence companies are arriving in force ​as governments boost military spending and seek lessons from conflicts that have highlighted the importance of ​drones, missile defence systems and artificial intelligence.

Monday's opening also coincides with the first day in office of Prime Minister-in-waiting Andy Burnham, who could make an appearance at the July 20 to 24 event.

Organisers say defence companies will make ​up half of a record 1,600 exhibitors at the show, highlighting a shift from the ​commercial aviation roots of an event that began in 1948 as a showcase for British aerospace technology.

The shift ‌reflects ⁠how conflicts from Ukraine to the Middle East have transformed spending priorities and accelerated demand for new defence technologies, including unmanned fighter jets, kamikaze drones and autonomous AI software.

On the eve of the event, the head of Boeing's commercial airplane unit said the company is focused on ​increasing and improving aircraft production, "not ​order announcement."

Sources told Reuters ⁠Airbus and Boeing are together expected to secure a little over 300 aircraft orders unless last-minute negotiations produce additional deals.

Among the expected announcements is ​an order for around 100 narrowbody aircraft from each manufacturer by ​Irish leasing ⁠company SMBC Aviation Capital, the sources said. Bloomberg News first reported the potential deal. None of the companies involved commented.

Other airlines discussing orders include Riyadh Air and Philippine Airlines.

However, there were no immediate ⁠signs of ​a breakthrough in talks between Turkish Airlines and engine ​makers over long-term maintenance agreements that the carrier has linked to a planned purchase of 150 Boeing 737 MAX jets.

Reporting ​by Joanna Plucinska, Dan Catchpole, Tim Hepher, Joe Brock and David Shepardson; Editing by Sharon Singleton

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Joanna reports on airlines and travel in Europe, including tourism trends, sustainability and policy. She was previously based in Warsaw, where she covered politics and general news. She wrote stories on everything from Chinese spies to migrants stranded in forests along the Belarusian border. In 2022, she spent six weeks covering the war in Ukraine, with a focus on the evacuation of children, war reparations and evidence that Russian commanders knew of sexual violence by their troops. Joanna graduated from the Columbia Journalism School in 2014. Before joining Reuters, she worked in Hong Kong for TIME and later in Brussels reporting on EU tech policy for POLITICO Europe.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© New Africa / Shutterstock.com

Picture a 66-year-old retired bookkeeper in rural Mississippi. She worked 40 years, raised two kids, and finished her career earning about $49,500 a year, almost exactly the national median wage. Her 401(k) balance is zero because her employers, mostly small local businesses, never offered one. Her checking account holds a few thousand dollars. Her monthly Social Security deposit is her entire retirement plan.

Her situation is not unusual. Roughly 46% of Americans have no retirement savings at all, and for many in the bottom half of American households by wealth, Social Security provides most, and often nearly all, of retirement income. The same $2,000 monthly check that a wealthier retiree treats as a bonus on top of a brokerage account is, for millions of others, the rent, the groceries, the Medicare Part B premium, and the electric bill.

According to Federal Reserve Distributional Financial Accounts data, the top 0.1% of U.S. households hold many times the wealth of the entire bottom 50% combined. JPMorgan (NYSE:JPM | JPM Price Prediction) CEO Jamie Dimon, discussing rising anti-wealth sentiment this summer, said it succinctly: “We have, in fact, left the lower-income folks behind.” One half has portfolios. The other half has a check from the Social Security Administration.

Why the Claiming Decision Is Higher Stakes at the Bottom When Social Security is a supplement, taking it at age 62 versus 70 is a lifestyle question. When it is the whole floor, it is the single most important financial decision a person will ever make. Claiming at 62 permanently lowers a recipient’s benefit by about 30% compared with waiting until full retirement age (FRA) of 67. Waiting until 70 adds roughly 24% on top of the FRA. On a $2,000 full-retirement-age benefit, that is the difference between about $1,400 a month for life and about $2,480 a month for life.

For a retiree with a 401(k), that spread might mean an extra vacation. For our bookkeeper, it is the difference between covering rent alone and needing SNAP and heating assistance every winter. Because the 2026 cost-of-living adjustment (COLA) is 2.8%, that gap compounds every year for the rest of her life. A higher starting benefit means a bigger COLA raise, forever.

For couples, a surviving spouse can step up to the higher earner’s benefit, which is why the higher earner in a couple delaying to 70 also buys longevity insurance for the widow or widower. The earnings test, which temporarily withholds benefits from workers under FRA who earn above roughly $24,480 in 2026, catches many lower-income retirees who try to claim early and keep working part-time.

SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now.

How the Rest of the Picture Fits For bottom-half earners, there is no meaningful drawdown strategy because there is little to draw down. The Saver’s Credit at the IRS can add up to $1,000 back to a still-working low-income saver who puts even $50 a month into an IRA. Supplemental Security Income (SSI) tops up benefits for those with very low income and assets. Medicare Savings Programs, run through each state Medicaid office, can pay the Medicare Part B premium (about $202.90 a month in 2026 for most enrollees), which alone represents a meaningful raise for someone living on $2,000.

As of Q1 2026, the national savings rate has fallen to 3.9%, down from over 6% just two years ago. Meanwhile, the University of Michigan consumer sentiment index hovers at recessionary levels. Households are not building the buffer that would ease reliance on the check.

What to Actually Do If Social Security will be most of your income, the highest-leverage moves are simple:

Delay if you possibly can. Waiting from 62 to FRA adds up to a permanent 30% increase, and each additional year worked past full retirement age up to 70 adds roughly 8% more. That raise is inflation-adjusted and lasts as long as you or a surviving spouse live. Coordinate as a couple. The higher earner delaying to 70 protects the survivor. This one decision often outweighs every other choice a lower-income couple will make in retirement. Claim the help you already qualify for. SSI, Medicare Savings Programs, LIHEAP, and SNAP have low take-up rates because people assume they will not qualify. Many do. The hardest mistake to undo is claiming early out of anxiety and locking in a permanently smaller check. The guaranteed, inflation-adjusted, lifelong nature of Social Security is exactly what makes it the right backbone for a household with no other cushion. For a fuller walk-through of the tradeoffs at each age, our team’s Social Security Decision report lays out the claiming math in one place. A quick sit-down with a benefits counselor at your local Area Agency on Aging can catch details a general article never will.

Want Up To $1,000? SoFi Is Giving New Active Invest Users Free StockLooking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts.

From $0 commission trading to fractional shares and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus. 

Contact [email protected] for any questions or corrections.

Joseph Gebbia, a Director at Airbnb, Inc. (ABNB 1.20%), sold 236,601 shares of Class A Common Stock on July 15, 2026, and July 16, 2026, for a total transaction value of $35.5 million, according to this SEC Form 4 filing.

Transaction summaryMetricValueTransaction value$35.5 millionShares sold (indirectly held)236,601Post-transaction shares2,096,256Post-transaction shares (directly held)2,738Post-transaction shares (indirectly held)2,093,518Post-transaction value$309.83 millionTransaction value based on SEC Form 4 weighted average sale price ($150.17); post-transaction value based on July 16, 2026, market close ($147.80).

Key questionsWhat was the primary mechanism for this disposition?
The sale was executed according to a Rule 10b5-1 trading plan established on Feb. 27, 2026. These plans allow insiders to schedule stock trades in advance to mitigate concerns regarding the use of material non-public information.How does this affect Joseph Gebbia's remaining exposure?
Following the sale of ~237,000 shares, the director continues to hold ~2.1 million shares. The vast majority of these holdings, totaling 2,093,518 shares, are held indirectly via the Sycamore Trust, while a residual 2,738 shares are held directly.What is the current valuation context for the transaction?
The shares were sold at a weighted average price of $150.17, while Airbnb shares were priced at $147.80 as of the July 16, 2026, market close. The company's stock had delivered an 8% return over the 12 months preceding the transaction.What are the fundamental characteristics of the company?
As of the transaction period, Airbnb reported trailing twelve-month revenue of $12.6 billion and net income of $2.5 billion. The San Francisco-based travel services company maintains a market capitalization of $86.6 billion and employs approximately 8,200 people.Company OverviewMetricValueShare Price (as of market close 2026-07-16)$147.80Market Capitalization$86.6 billionRevenue (TTM)$12.7 billionNet Income (TTM)$2.5 billionCompany SnapshotAirbnb operates a global digital marketplace that enables hosts to list accommodations ranging from private rooms and primary residences to vacation homes, generating revenue through booking commissions and service fees from guests worldwide.The company's business model leverages a two-sided platform that connects supply (hosts offering accommodations) with demand (guests seeking lodging), capturing value through transaction-based fees on each completed booking.Airbnb's primary customers include leisure and business travelers seeking alternative accommodations, as well as property owners and hosts looking to monetize residential spaces in a global market.Airbnb operates as a leading global digital marketplace for short-term lodging and experiences, with a market capitalization of $86.6 billion and TTM revenue of $12.6 billion. The company's competitive advantage derives from its expansive network of hosts, proprietary technology platform, and brand recognition in the travel services sector. As of the most recent period, Airbnb maintains a strong financial position with TTM net income of $2.5 billion, demonstrating the profitability of its asset-light, commission-based business model.

What this transaction means for investorsIt would be more encouraging if Airbnb’s largest shareholders were keen to retain all their shares. That said, this insider sale probably isn’t anything to get worked up about. It was conducted through a trading plan set in motion nearly five months earlier. The important thing to remember about these plans is that they can usually be terminated if an insider believes that great news could become public knowledge in the near future.

Airbnb will release results from the second quarter of 2026 after the market closes on Aug. 6, 2026. During the first quarter, the online reservation business reported gross booking value that soared 19% year over year, or 13% excluding the benefits of a weaker dollar.

It looks like the jump in booking value came on the heels of significant price increases or a shift toward higher-priced accommodation. The number of nights and seats booked rose just 9% year over year to 156.2 million.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Airbnb. The Motley Fool has a disclosure policy.

1.02K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of TSM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Obchodní aktivita amerických politiků je investory dlouhodobě bedlivě sledovaná. V minulých letech byly pod drobnohledem především investiční kroky bývalé šéfky Sněmovny reprezentantů Nancy Pelosiové (a jejího manžela), od návratu Donalda Trumpa do Bílého domu se pak více pozornosti upřelo právě na něj. Americký prezident v posledním majetkovém přiznání zveřejnil tisíce transakcí uskutečněných prostřednictvím svěřenského fondu. Server Benzinga se podíval na portfolia obou politiků a našel v nich hned desítku shodných titulů.

Společným jmenovatelem většiny shodných pozic jsou technologické firmy a společnosti profitující z rozvoje umělé inteligence. Na seznamu tak figurují jak zástupci Magnificent Seven, tak ale třeba i méně tradiční sázky typu Tempus AI či energetická skupina Vistra.

Mezi nejčerstvějšími přírůstky v portfoliu rodiny Pelosiových jsou Uber a Intel. Paul Pelosi podle zveřejněných dokumentů nakoupil dlouhodobé call opce na obě společnosti s expirací v příštím roce. Trumpův svěřenský fond mezitím letos u obou titulů vykázal kombinaci nákupů i prodejů, přičemž převažovaly nákupní transakce.

Výrazný překryv pak lze zpozorovat u největších technologických společností. Pelosiovi dlouhodobě drží expozici vůči Alphabetu, Nvidii, Applu, Amazonu a Broadcomu, často prostřednictvím opcí, které byly následně převedeny na akcie. Trumpův fond zase během letoška uskutečnil u těchto jmen desítky obchodů, přičemž některé transakce byly v řádu milionů dolarů.

Zvláštní pozornost pak poutá Nvidia, která se stala jedním z hlavních symbolů boomu umělé inteligence. Pelosiovi v posledních letech opakovaně navyšovali svou expozici vůči nejhodnotnější veřejně obchodované společnosti na světě, zatímco Trumpův fond patří mezi nejaktivnější obchodníky s tímto titulem, odhalila analýza serveru Benzinga.

Kromě zavedených technologických gigantů spojuje obě portfolia také orientace na perspektivní segmenty. Zde můžeme zařadit Tempus AI, jež využívá umělou inteligenci ve zdravotnictví, nebo velkého hráče v oblasti kybernetické bezpečnosti Palo Alto Networks. Dalším méně očekávaným jménem je pak energetická společnost Vistra, kterou investoři často vnímají jako nepřímou sázku na rostoucí spotřebu elektřiny datových center.

Deset akcií, které se letos objevily v portfoliích Pelosiové a Trumpa:

Uber Technologies
Intel
Alphabet
Nvidia
Tempus AI
Vistra
Apple
Amazon
Broadcom
Palo Alto Networks

Odlišné investiční přístupy

Benzinga si také všímá toho, že i přes shodu u některých titulů se styl obou táborů výrazně liší. Paul Pelosi je známý využíváním dlouhodobých call opcí, které následně převádí na akcie. Jeho strategie se soustředí především na velké technologické společnosti a strukturální růstové trendy.

To Trumpův svěřenský fond naopak podle zveřejněných údajů realizoval během let 2025 a 2026 desetitisíce transakcí napříč řadou sektorů. Přesto i zde dominují velké americké společnosti a zejména technologické tituly, které tvoří významnou část nejaktivněji obchodovaných pozic.

NEW YORK, July 19, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Peabody Energy Corporation (NYSE: BTU) between October 14, 2024 to May 4, 2026, inclusive (the “Class Period”), of the important August 24, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Peabody Energy common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Peabody Energy class action, go to https://rosenlegal.com/cases/peabody-energy-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 24, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Peabody Energy’s Centurion mine and the multitude of issues causing delays to the ramp-up and the return to full longwall production dates. On March 30, 2026, Peabody Energy issued a press release lowering guidance pertaining to Centurion mine’s expected first quarter 2026 output ahead of Peabody Energy’s full earnings release. In pertinent part, defendants announced that sales volume from the Centurion mine was expected to deliver approximately 250,000 tons in the first quarter due to mining commissioning challenges (compared to previous estimates of around 700,000 tons). When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Peabody Energy class action, go to https://rosenlegal.com/cases/peabody-energy-corporation/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Once the Magnificent Seven's most enthusiastic fans, they are looking elsewhere for the next superstar tech stocks.

, /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Planet Fitness, Inc. (NYSE: PLNT) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Planet Fitness, Inc. securities between November 6, 2025 and May 6, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/PLNT.

Planet Fitness, Inc. Case Details

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

Planet Fitness' updated marketing messaging was failing to resonate with, and was actively intimidating, its core target demographic of fitness beginners and casual gym-goers; as a result, the Company was experiencing significant headwinds in net member growth during its critical first-quarter sign-up period, rendering its previously issued fiscal 2026 guidance and long-term financial targets unattainable; contrary to Defendants' representations, Planet Fitness would be required to restructure its marketing strategy, forgoing the benefits it claimed would result from continuing its existing marketing campaign, and abandon its planned Black Card membership price increase upon which its sales projections were based; and as a result of the foregoing, Defendants' statements about the Company's business, operations, financial guidance, and prospects were materially false and misleading at all relevant times. What's Next for Planet Fitness, Inc. Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/PLNT. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Planet Fitness, Inc. you have until September 14, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Planet Fitness, Inc. Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Planet Fitness, Inc. Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.

SOURCE Bronstein, Gewirtz & Grossman, LLC

New York, New York--(Newsfile Corp. - July 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Planet Fitness, Inc. (NYSE: PLNT) between November 6, 2025 and May 6, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 14, 2026.

SO WHAT: If you purchased Planet Fitness common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Planet Fitness class action, go to https://rosenlegal.com/cases/planet-fitness-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 14, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made materially false and misleading statements and/or concealed material adverse facts concerning the true state of Planet Fitness' customer acquisition and marketing metrics. Notably, Planet Fitness' updated marketing messaging was failing to resonate with, and was actively intimidating, its core target demographic of fitness beginners and casual gym-goers. As a result, Planet Fitness was experiencing a significant headwind in net member joins during its peak first-quarter sign-up period that rendered its previously issued fiscal 2026 guidance and long term financial targets unachievable. Instead, Planet Fitness would be required to restructure its marketing strategy, losing the gains they praised from continuing the same marketing campaign, and entirely halt the planned Black Card price increase which sale projections were premised upon. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Planet Fitness class action, go to https://rosenlegal.com/cases/planet-fitness-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305741

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

CoreWeave: Consistent Revenue ExpansionCoreWeave (CRWV +0.60%) operates a specialized cloud computing environment that provides bare-metal virtual servers, storage solutions, and advanced networking resources for enterprise clients.

It recently faced a class action lawsuit regarding customer demand statements, and it reported a -36% net income margin for the quarter ended March 31, 2026.

Applied Digital: Managing Data Center OperationsApplied Digital (APLD 2.46%) designs, develops, and manages digital infrastructure and data center solutions for high-performance computing industries and specialized hosting customers across North America.

It completed the separation of its cloud business into a new entity on May 5, 2026, while recording a -78% net income margin for the quarter ended Feb. 28, 2026.

Why Revenue Matters for Retail InvestorsRevenue shows the total money a business brings in during a specific period before any expenses are deducted, helping investors gauge the overall size and scale of operations.

Quarterly Revenue for CoreWeave and Applied DigitalQuarter (Period End)CoreWeave RevenueApplied Digital RevenueQ2 2024$395.4 million (period ended June 2024)$14.7 million (period ended May 2024)Q3 2024$583.9 million (period ended Sept. 2024)$60.7 million (period ended Aug. 2024)Q4 2024$747.4 million (period ended Dec. 2024)$63.9 million (period ended Nov. 2024)Q1 2025$981.6 million (period ended March 2025)$52.9 million (period ended Feb. 2025)Q2 2025$1.2 billion (period ended June 2025)$38.0 million (period ended May 2025)Q3 2025$1.4 billion (period ended Sept. 2025)$64.2 million (period ended Aug. 2025)Q4 2025$1.6 billion (period ended Dec. 2025)$126.6 million (period ended Nov. 2025)Q1 2026$2.1 billion (period ended March 2026)$126.6 million (period ended Feb. 2026)Data source: Company filings. Data as of July 16, 2026.

Foolish TakeCoreWeave and Applied Digital share a symbiotic relationship. Applied Digital rents out its data centers to CoreWeave. That adds an interesting twist to the revenue comparison between the two, since CoreWeave sales are soaring while Applied Digital is showing a more modest pace of growth, an indication of the differences in their business models.

CoreWeave’s focus on renting out computing power to artificial intelligence customers is driving its spectacular sales expansion. In the first quarter, revenue surpassed $2 billion, and the company announced a backlog of business worth nearly $100 billion. This bodes well for a continuation of its sales growth trend. However, supplying the equipment needed to support AI is expensive, and the company has amassed about $25 billion in debt at the end of Q1.

As a data center landlord, Applied Digital enjoyed a 139% year-over-year increase in revenue to $126.6 million for its fiscal third quarter ended Feb. 28. But like CoreWeave, it had to take on debt to continue building data centers with about $2.6 billion on its fiscal Q3 balance sheet.

The high debt load for each has turned off Wall Street investors, leading to a drop in share price for both companies. But of the two, CoreWeave’s price-to-sales ratio of six is around a low point for the past year, while Applied Digital is far more expensive with a sales multiple of 21.

In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Tyler Crowe, Matt Frankel, and Jon Quast discuss:

Meta’s new AI models and pricing strategyDoes Meta have a strategy or just “trying things”?Is GE Vernova overvalued?Can American Tower overcome its challenges?To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.

A full transcript is below.

This podcast was recorded on July 9, 2026.

Tyler Crowe: Meta is making even bigger AI bets today on Motley Fool Hidden Gems Investing. Welcome to Motley Fool Hidden Gems Investing. I'm your host, Tyler Crowe, and today, I'm joined by longtime contributors, Matt Frankel and Jon Quast. Today we're going to dive into a couple mailbag questions. We got questions about GE Vernova. We got questions about REITs, which I think definitely had Matt excited to talk about today. But we want to start today with two relatively large announcements from Meta Platforms today, all of which related to AI. One of them was the launch of its Muse Spark 1.1 artificial intelligence model, the next iteration of what they've been doing with AI models. The second was it announced its plans to put its own AI chip into production. It's going to start in September with both Broadcom and Taiwan Semi as kind of the designers, manufacturers, helping them build out their own chip production capacities. Now, guys, these sound like really big moves. Help me wrap some context about what we're seeing here with these.

Jon Quast: As far as the model goes from Meta Platforms, this is actually a pretty big upgrade in a couple of areas. You wouldn't normally be inclined to think so. I was tempted to overlook this just going from 1.0 to 1.1 here with Muse Spark. But in here that I think is significant, one is the context window. They're going to provide a 1-million-token context window. What this does is it allows an AI agent to essentially work longer on a task without forgetting what it's doing. That's actually a problem with some models out there. You'll send an AI agent to work. It loses context, it forgets what it's doing, it keeps working and keeps spending your money. That's a problem. A 1 million token context window, this is roughly four times as big as the 1.0 Version of Muse Spark. That's a really significant upgrade.

The other big change here that I'm seeing here is, this is a this is now being launched to people to use. There's pricing to go with this. If you look at the pricing, it's more than 50% times cheaper than competitive products from Anthropic and OpenAI. That's both for the input and the output. That is really significant when you think about these two businesses because anthropic and OpenAI, they need the products that they have out there. That's what they do. Meta has a whole other business paying the bills, and it does this on the side. It has the luxury of this aggressive pricing. That is something really significant to note with Muse Spark 1.1.

Matt Frankel: With the chips, I'm not sure if it's as significant as the model. This is essentially what Google and Amazon do. These chips, as Tyler mentioned, they're designed with the help of Broadcom and manufactured by Taiwan Semi. This is the essential model that Apple uses to design its own iPhone chips. The goal here is to really reduce the company's dependence on Nvidia and AMD processors that are really expensive as the company aims to build out its compute power and double it again next year, really the idea is that these chips are going to handle the easier side of AI tasks. They're still going to need the more powerful Nvidia ones for.

Tyler Crowe: I want to put this in context of everything we've seen from Meta recently because this to me seems like the biggest major announcement or it's a couple in what I would say is major announcements for Meta. It's been using a lot of creative financing to build data centers. To your point, the amount that they're adding this year, doubling that next year, it's made some announcements with Smart Glasses. It recently announced a prediction market asset. I know I'm missing a few deals in announcement there, but I think it gets to the broader point, there's a lot of things going on here.

When I look at Meta and I see all of these things that it's doing, I am less impressed. I see an unfocused company that's throwing a lot of spaghetti at the wall to see what sticks. The company seems to be all in with these new ideas that end up maybe not doing as much and it all reverts back to the basic advertising model that they've had for so long with Facebook, Instagram, what have you. Now, I brought this up before, but the company really dodged a bullet, I would say, with all of that investment in data centers for its reality labs, virtual reality efforts, being able to basically pivot quickly to AI and be like, we don't have to write this down because now it's all AI stuff. Here's my broader question, putting all that in context. Should investors be excited about these new moves and things that they're doing? Because to me, I just see an undisciplined company trying to look like something that it isn't.

Matt Frankel: Well, throughout Meta's history, the company has proven that it's exceptionally good at doing one thing, and that's making money from its core advertising business. If you compare Facebook's average revenue per user to that of Pinterest or Snap, for example, it's not even in the same ballpark. But to your point, Tyler, any attempt that they've made, and they've made quite a few to build out a second significant revenue stream, hasn't really gone anywhere. All the metaverse spending you mentioned.

As far as the chips are concerned, I'm not really sure what to make of it from a potential standpoint. On one hand, if it meaningfully reduces their spend on Nvidia and AMD GPUs, it could be a positive in the sense that their capex is going to go a longer way when they're building out all their compute power. But on the other hand, they're still going to have to buy a lot of Nvidia and AMD chips. They actually signed the biggest AI deal in history to buy AMD chips for the hardest AI jobs. In the near term, focusing on building out their own chip production could actually increase the company's capex needs.

In a nutshell, they're doing what Google and Amazon have already been doing for years, building chips to handle the easier AI workloads and still relying on Nvidia and AMD for the rest. This could be an efficiency win for the company, but I really don't see it as a major needle movers, even in terms of cost structure. If it pans out as expected, I'd actually see it as a bigger needle mover for Broadcom than I would for Meta.

Jon Quast: If we say that Meta is just throwing spaghetti at the wall, then I say, Andiamo Mangare, let's eat because this is actually going really well for them. You look at 2025, 20% growth in income from operations. We come into 2026, it's accelerated even more. We have a 30% jump in income from operations. I know that we can say that the gains are coming from that core advertising business, and that's a fair point, but I don't know if it's so simple. I don't know if we can completely disassociate all that it's investing into AI and say, "Well, that's over here and the advertising business is over there."

I think that in reality, there's more overlap between the two than we can really parse out. I do believe that there are some gains happening as a result of it's investing in the AI side of the market. I think it's good investment. The growth speaks for itself. Growing at this scale at this speed, it's doing something even if it's throwing spaghetti at the wall. On top of that you have a stock here that is cheaper than the overall market at just 22 times earnings and growing this fast. I don't know. It's hard to find too much for me to complain about with Meta.

Tyler Crowe: I didn't have Jon speaking Italian on my Bingo card for today. Coming up next, we're going to get into listener questions. First one on GE Vernova.

ADVERTISEMENT: Indeed present. Hires you can't afford to get wrong. Like warehouse operations manager. Where are the forklifts? I sold them. They were too expensive. I've got a great deal on these scooters, though. You expect us to move a two-ton palette on a scooter? It'll be fun. Just think of the core strength you'll build. This is a job for sponsored jobs. This is what happens when you don't sponsor your job on Indeed. The next time you need someone to get the job done right, get matched with quality candidates with an Indeed-sponsored job. Visit indeed.com/nextie and sponsor your job today.

Tyler Crowe: Hey, everyone, just a quick reminder. If you do want to get a question into us, have it answered by us on air, go ahead and email us at [email protected]. That's podcast with an S @fool.com. Just remember, keep it Foolish, keep it short and don't ask for personalized advice, so we don't get in trouble with the SEC. Today's question comes from Steven Cox, and it says, "Hello, Fools, I was wondering if the team on the Hidden Gems Investing podcast could cover GE Vernova. I really love the company and think it's an essential player to the future, but it seems to be priced to perfection regardless. What does the team think?" Jon, I'm going to let you start, and then we'll see where this goes because I have some pretty deep thoughts here.

Jon Quast: My thoughts probably not as deep. Right before it was spun out when GE split up into different companies, I was tasked with writing an article for fool.com on GE Vernova and diving down deep into that at the time, I really came away just impressed with this business. I like this business. I was hesitant to invest only because it's not a space I typically follow, and I was nervous I didn't hear other people talking about it. I just doubted myself, but wow, what a mistake to not invest. This has been an incredible stock since GE spun it out. I believe it's up over 700%. What I will point out here is that most of the gains recently have been valuation, and just take that for what it's worth.

Essentially the business is doing one thing, the valuation is driving a lot of the stock gain. Let's just pretend for a moment here as we try to say, here's where we are now. Let's assume no expansion or contraction in the valuation from here. What can this business do for shareholders? You look at the business right now, that revenue growth in the most recent quarter, 16% growth for a business of this size, maturity, for the products that it offers with energy generation, solar, wind, turbines, many things, you look at that growth. That's really quite outstanding. Then you look at the backlog. Even greater growth than the revenues. That would point to ongoing gains in the revenue.

I do think that you have a business here that might be able to produce 15% annual returns for the stock. You add in things such as the dividend, the buybacks, all these things. Maybe a 15% when you just look at the business fundamentals itself. Now you take a step back and say, "Okay, but what about the valuation?" I don't think that's going to be a tailwind from here on out, just looking at the valuation today. Probably a little bit of a headwind, how much of a headwind? That's what I personally don't know.

Matt Frankel: Let me chime in before Tyler gives his deep thoughts here. There's a solid argument to be made that Vernova is the best position power stock for the AI infrastructure build-out. Just look at its backlog. It's $163 billion backlog. It expects that to reach $200 billion by next year. The company's electrification segment, which deals with grid equipment, transformers, and other components. It booked more data center orders in the first quarter than it did in all of 2025. Their turbine production. It's essentially sold out for almost a decade into the future. I push back on Jon a little bit that yes, the valuation has outgrown the business, but there's a lot, especially all the things that I just mentioned that aren't really showing up in the numbers quite yet.

On the other hand, this is an expensive stock, even if you consider that backlog, the growing order book, the bull case essentially assumes that the demand cycle we're seeing is going to last for years into the future. The reality is there are physical constraints on their ability to fully capitalize on that demand. My bottom line on Vernova is that the demand is clearly there to justify today's pricing. The company has more orders than it can physically build for many years, but that valuation only holds up if that demand holds up for the next decade or so, and there isn't any significant kind of breaks in that AI capex story anytime soon. Tyler, onto your deep thoughts.

Tyler Crowe: There was actually a reason I picked this one specifically, and the reason we did is because GE Vernova was actually a recent recommendation in the Hidden Gem service, and I wanted to get that out there. I did even clear it with marketing and say if we could say that on the free site, but I wanted to get that out there. Steven, you seem to be in tune with what we're thinking here. Normally, of the three of us, I would probably be the most homogeny with valuation, but I'm going to make the case to you guys that even when you look at this valuation today, looking at the energy space in general, this is probably one of the companies actually worth paying up for.

Let me get into why. You were talking about its backlog of equipment and orders that it has for new turbines, because it makes turbines for every type of power. It's natural gas turbines, hydroelectric turbines, coal turbines, nuclear power, anything that runs a turbine for electricity, GE makes it, and there's three companies in the world that make up two-thirds of the market for this. It's them, it's Siemens and Mitsubishi. Here is the most interesting aspect of their business. They don't make a lot of money selling the actual turbine. It's maybe high single digits, maybe 10% margin. When they're lucky on these engines, it's not much. The actual money is made servicing aftermarket parts and service for decades after the actual turbine is sold.

When you have these really high periods of engine orders, it actually has some of the lowest margins in its business because its aftermarkets parts and service business is nearly triple the margins that they get for equipment orders. Right now, it's arguably at one of its lowest margin points in its period because as it builds out that fleet of turbines that it's going to be putting in every single piece of power equipment out there, those long-term orders of aftermarket sales, servicing, checking in on the things, maintenance, and stuff like that. That's going to be much higher margin, much higher return business that lasts for decades after that thing is actually installed. Not only do we have a decade runway of orders coming in, you have a decade of fleet build-out.

Right now, there's about 400 gigawatts of GE Vernova turbines powering something in the world right now, and they're expecting over the next five to seven years to put 200 gigawatts of additional power out there. They're almost adding 50% to their fleet, and that's going to give that long term service sales aftermarket business. When I look at GE Vernova, of all the businesses out there that I want to pay up for, I want to pay up for this one because I have so much more visibility into the long-term aspects of the business relative to some of the other one-time sales that you might have with the infrastructure build out with electrification.

Jon Quast: Tyler, I listen to you talk. The first thing I ask myself is where were you when I needed you two years ago? But the second thing I ask is you're saying all this, but you don't own the stock today, so what would actually get you off the sidelines and into the buyer’s arena?

Tyler Crowe: Well, one, Motley Fool trading restrictions says that I can't buy it right now. We'll start with that. But this has been a candidate for me for a little while. To your point about two years ago, it was funny when they spun GE Vernova out. It actually looked like the problem child of the three companies. I think we talked about this with the Honeywell spin-offs a couple of days ago where it's like they had all these bad servicing contracts with wind and all these other things. Everyone thought that GE Healthcare was going to be the gem that threw off all this cash and was going to reward investors, and lo and behold, Vernova has become the true champion here. I don't own it. Probably, I should throw my hand up and say guilty as charged, but perhaps once the trading restrictions that we have now that I've talked about it, I can't trade or buy it for a few more days. But certainly it’s something I'm going to be putting on my radar this coming time soon. Coming up next, we're going to get another listener question going into the real estate investment trust.

ADVERTISEMENT: People who are psychopathic just don't intrinsically value other people's welfare that much. Every interaction is about, what can I get? What can I get out of this person? What can I get out of this situation? That’s why there’s so much manipulating and lying and exploitation, is it because people, most of the time, are just tools to get whatever the ultimate goal is. All of us know somebody with psychopathy. To hear the science behind who actually does the most harm, check out episode 1293. It might change how you see everyone around you.

Tyler Crowe: We don't normally do two questions or listener questions in any given show, but we had to do two this time because we actually got a question specifically for one of our guests on the podcast, and we had a question come in from Bruce Clark, who asked specifically for Matt's opinions on something. Here we go. Matt, question about American Tower, AMT is the ticker. The question is, "Is the debt manageable and will satellite technology erode the land-based tower business?" Yes, just for some context for people who may not know, American Tower is a real estate investment trust that specializes in owning the towers that companies like Verizon, T-Mobile, AT&T all of their communications equipment on. Basically, it's the landlord for the telecommunications network. With that slight introduction and because we need to feature Matt in this whole section, Matt, what do you got?

Matt Frankel: Well, first American Tower, to add to your company description, their name is misleading because they are not just American. They are literally all over the world. They have towers all over the place, and their chief rival, Crown Castle International, is only in America. I've always argued they should swap names. Bruce is right, their debt is elevated. A debt-to-EBITDA ratio of 4.9 is on the high end for a REIT. They have 4X interest coverage, meaning that their earnings before interest and taxes are roughly four times what they're spending on interest on their debt. That's comfortable but not ideal.

The company, they've done a solid job of extending their debt maturities at favorable interest rates, but the debt pay-down hasn't been as much of a priority as I feel it should have. For example, they just raised their dividend by 5%. They've been buying back stock, which is rare for a REIT. While I get it, the stock is cheap on paper, as I'll talk about in a minute. I feel like de-leveraging would be a somewhat better use of their money. I'm not worried about the debt in the sense that it's any real existential threat to the company, but I would love to see somewhat of a shift in capital allocation over the next couple of years.

Jon Quast: It's hard for me to imagine that we would see much of a shift, though. Because a lot of those capital allocation priorities, they're hard to move around too much. As a REIT, we pay out 90% of the taxable income. But then there's also expectations from investors that we are going to raise our dividend on a regular cadence and not change where we're putting that money. I was just looking at this. American Tower paying over $1 billion in interest payments annually and roughly $3 billion in dividend payments annually. Wouldn't you say that high debt load does impact the ability to raise the dividend? I know that there is some flexibility, but I don't know, at a 4% yield, that's good, but not necessarily great for a REIT. Wouldn't you say there are probably better options out there with lower leverage?

Matt Frankel: I would agree. That's one of the reasons I don't own the stock directly. I have plenty of exposure through ETFs because it's one of the biggest REITs in the market. But yeah, I would say there are better options with a lower leverage if you're just looking for a 4% yield from your investment with some upside. But you're right the debt load, it does constrain them on how much they can raise their dividend. There's a lot to unpack with the 90% of taxable income they have to pay out. That's for a whole other show. But yeah, there are some better options if you want a lower leverage REIT with a high dividend yield.

Tyler Crowe: I want to hit on the second part of the question, too, because I think it touches with a lot of what we've been talking AI and space and all that stuff because there has been this new concept of going out there. It's like, well, we're just going to put data centers in space and we're going to put satellite communications in space and we're going to render a lot of land-based communication data centers is useless. This really is American Tower's business. To the second part do you see those endeavors, satellite communication disrupting land-based telecoms or data centers in space? Is that going to basically upend American Tower here, or do they still have some legs?

Matt Frankel: The satellite direct-to-cell ambitions. You see companies like Starlink, like AST Space Mobile. It's a threat that's worth watching, but there are some physical constraints with what they're trying to do, essentially be an emergency backup. If you have your cell phone and you go into an area that doesn't have cell coverage, it would kick over to the satellite. Just for example, the direct-to-cell satellites that exist today anyway are not very good at providing coverage when you're indoors. That's a big obstacle to overcome. Because of things like that, for at least the next few years, this is likely to be a complement, not a replacement to these dense tower networks like American Tower operates. It's worth watching, but for the foreseeable future, I'm not worried about it.

Jon Quast: The only thing that I'd add here is that everything that Matt said can be true, and yet there can still be a huge greenfield opportunity for the direct-to-cell satellite companies simply because there are areas where an American tower or other cellular service land-based is not available. You think about remote areas of the USA, that's one thing, but internationally, there's just not the infrastructure in many countries that we enjoy in this country or even in many developed Western countries. There are plenty of places where it's not a competing product. It's wide open to whoever can get the coverage there, and in many cases, the most obvious path would be a satellite communication. The satellite communication companies can grow substantially without even infringing on the existing land-based turf.

Tyler Crowe: I think I mentioned this when we were doing our show about the SpaceX S-1 of when I lived in West Africa for a while, I tried to sign up for Starlink because, you know, the land-based options were relatively limited. To this point, I don't think that it's going to disrupt a lot of the existing systems that American Tower has because that's infrastructure there. It's pretty cheap. But the growth levers that the company has been pulling in international markets, it does have a very large presence in Africa. It could limit that if satellite communications now start to really drop in prices and make it comparable for places like that. I'm guessing by everyone's assessments here, it's like, it's a decent business. It pays an OK dividend. Probably overleveraged with some long-term threats that maybe it’s fine, but maybe not the best investment out there today. Fair assessment, guys?

Matt Frankel: Yeah. There's a lot to like about American Tower right now. The core tower business is performing better than expected recently. In the first quarter, revenue was up 7%. Earnings were above expectations. The company owns the core site data center business, so this is not just a tower REIT. They actually made one of the big data center acquisitions of the past few years, and that's growing at a double-digit pace for obvious AI reasons. The stock trades at 15 times funds from operations, which is essentially the REIT version of earnings. Pretty cheap, 4% dividend yield, as we've talked about a minute ago. Historically, that's very cheap for this company. I am not a shareholder, and I probably won't be, but really for the same reason I don't own Nvidia. It's because I have a ton of exposure through the S&P 500 index funds I own, because it makes up like 7% or 8% of them. It's the same thing with American Tower with the real estate index funds I own. Not going to be a shareholder myself, but there's a lot to like about the stock.

Jon Quast: For me, American Tower isn't on my radar for a different reason, and that's that I usually don't go for REIT stocks, and I normally don't go for anything commercial real estate, just not my thing. Especially when I consider why would I potentially want to invest in American Tower? It would be for the dividend. At 4% I can pick a different stock that I understand better and like better, and that makes a lot more sense to me. One in my portfolio now for its dividend would be Pepsi. I just think that Pepsi is a rock-solid business. I don't think it's going anywhere, even with some current doubts, I guess, from the investor community. I think that its business is going to exist for my lifetime, and it pays a comparable dividend. A business I understand better, like better and paying the same dividend. For me, that makes more sense than investing in something I don't really know.

Tyler Crowe: We'll go with a lukewarm. It's OK, but maybe take a look at Pepsi instead.

As always, people on the program may have interest in the stocks they talk about, and the Motley Fool may have formal recommendations for or against, so don't buy or sell stocks based solely on what you hear. All personal finance content follows Motley Fool editorial standards, and it's not approved by advertisers. Advertisements are sponsored content provided for informational purposes only. To see our advertising disclosure, please check out our show notes. Thanks for producer Dan Boyd and the rest of the Motley Fool team. For Matt, Jon, and myself, thanks for listening, and we'll chat again soon.

Free cash flow conversion is now the single most important determinant of share price. Burdening company valuation for the moment, I expect FCF conversion to help Microsoft's long term upwards trajectory when it comes back to more sustainable levels in the late 2020s. Impressive margins in Software and strong growth in Cloud dispel return on investment fears.

Bank of America has reportedly promoted new leaders to guide its artificial intelligence and crypto efforts. Sonali Theisen has been named the bank's head of global digital-assets platform and Kevin Milsom head of platforms AI transformation, Bloomberg News reported Friday (July 17), citing an internal Bank of America (BofA) memo later confirmed by the company.

On Tuesday, July 14, IBM (IBM 2.91%) stock plunged 25.2% after the technology giant released selected preliminary second-quarter 2026 financial results. Its full, official report is scheduled to be released on Wednesday, July 22, after the market closes.

This was Big Blue stock's largest percentage drop since at least January 1968, when modern daily pricing records began. And it was the largest-ever drop in dollar terms, with shares losing more than $73, falling from $290.23 to $217.07.

It is very unusual for a well-established, profitable, large-cap company -- a so-called blue chip company -- like IBM to suffer such a steep one-day stock loss. Granted, the preliminary Q2 results were not good, but they weren't terrible either, so why such a massive sell-off?

Image source: Getty Images.

Second-quarter 2026 preliminary results missed Wall Street's expectations In a letter to shareholders, CEO Arvind Krishna said IBM expects to report Q2 revenue increased 1% year over year to $17.2 billion and adjusted earnings per share (EPS) – what the company calls "operating EPS" – increased 4.6% to $2.93 when it releases its official report.

Both results fell notably short of Wall Street's consensus estimates, which were for revenue to rise 5% to $17.86 billion and adjusted EPS to grow 7.9% to $3.02.

Breaking down the total revenue growth of 1% year over year, software revenue was up 5%, consulting revenue was flat, and infrastructure revenue was down 7%.

Q2 preliminary results fell short of IBM's own guidance, too Big Blue's preliminary results also missed its own expectations. Here's part of what CFO Jim Kavanaugh had to say about the company's annual and second-quarter revenue guidance on the first-quarter earnings call in April:

The strong start to the year drives our confidence in delivering constant-currency revenue growth of 5-plus percent in 2026... Our revenue expectations are underpinned by our accelerating software business, which we now expect to grow 10-plus percent this year.

Looking to the second quarter, we expect our constant-currency revenue growth rate to be similar to the full-year rate [5%].

What did the CEO attribute as the reasons for the disappointing preliminary Q2 results? The software and infrastructure segments underperformed the company's expectations. Here's what Krishna said in the investor letter:

[W]e expected Infrastructure revenue to decline low-single digits for the year, beginning this quarter. What played out was worse than our expectations, driven by a shortfall in our Z [mainframe] performance and the associated software stack, primarily in Transaction Processing. In the last few weeks of June, we saw clients shift their quarterly capex spend toward servers, storage, and memory purchases to secure supply constrained infrastructure ahead of expected price increases. [Emphasis mine] ... While we anticipated some supply chain-related impact in our expectations, we did not anticipate the magnitude of the capex reprioritization.

This capital expenditure shift among major customers involved increased spending on artificial intelligence (AI)-enabling hardware at the expense of IBM's largely software offerings.

Today's Change

(

-2.91

%) $

-6.38

Current Price

$

212.67

Why such a huge stock drop, as the preliminary results were not terrible? The huge stock drop in the face of disappointing but not terrible quarterly results suggests that a good number of investors expect Q2 to not be a one-off and anticipate that the company will likely cut its 2026 annual guidance on July 22, when it releases its full, official results. I think it's more likely than not that IBM will lower its annual guidance.

Investors have had high expectations of IBM. After all, IBM stock has had a strong run in recent years. Before Tuesday's sell-off, shares had returned 139% over three years – nearly twice the S&P 500's index 73%.

What should an investor do now? I would not recommend making an investing decision about IBM stock now, as there are too many uncertainties. Wait until at least after the upcoming earnings call, when we should learn whether the large deals IBM expected in the second quarter but did not materialize were simply pushed back or halted indefinitely. That's a crucial difference.

Some investors buy IBM stock largely for its dividend, so it makes good sense for them to keep holding the shares. On that note, a silver lining to the stock sell-off is that the dividend yield has increased. Shares are now yielding about 3.18%, as of Friday's market close. IBM has increased its quarterly cash dividend for 31 consecutive years.

Another good reason to hold shares is that IBM is widely considered a leader in quantum computing. It was an early entrant in this developing technology and could be a major beneficiary once the tech begins to be widely commercialized.

On June 22, AbbVie (ABBV +0.04%) announced that it would acquire Apogee Therapeutics (APGE 0.06%) for $10.9 billion in cash. Some investors celebrated the move, since it will add zumilokibart, a promising investigational medicine for eczema, to AbbVie's lineup and help it solidify its leadership in immunology. However, others may fear that, given how much it will spend on this buyout, the transaction may impact AbbVie's dividend program, one of the company's key selling points. My view is that income seekers have nothing to worry about. Here's why.

Image source: The Motley Fool.

A precedent that speaks volumes Expensive acquisitions can put downward pressure on a company's dividend program if they significantly reduce the cash available to be returned to shareholders. With AbbVie ending 2025 with $17.8 billion in free cash flow, some fear that this is what will happen. But it's worth noting that AbbVie is a Dividend King, or a corporation with 50 (or more) consecutive years of dividend increases, once we factor in the time it spent under Abbott Laboratories' wing.

Management is committed to maintaining this streak, because if AbbVie misses a single year of dividend increase, it will have to start from scratch and hope to join the ranks of Dividend King again in another 50 years. Besides, AbbVie will fund the acquisition with debt, meaning it won't deplete its cash balance.

It's worth considering how the largest acquisition in AbbVie's history -- and one of the largest ever in the pharmaceutical industry -- impacted its dividend program. The company bought Allergan for $63 billion in a mix of cash and stock in May 2020. This massive transaction did not harm AbbVie's dividend. Since 2020, the drugmaker's payouts have increased by 46.6%.

Today's Change

(

0.04

%) $

0.09

Current Price

$

254.48

The business is improving AbbVie's acquisition of Apogee Therapeutics may also lead to the company launching zumilokibart. This product could help drive solid revenue, earnings, and free cash flow growth, thereby strengthening the business and helping it maintain its dividend program. Once again, that's arguably what the Allergan acquisition did for AbbVie. The drugmaker was able to expand and diversify its lineup thanks to it, and products such as its Botox franchise and Vraylar, a schizophrenia medicine, helped it move beyond Humira's patent cliff.

So, this buyout will arguably be a net positive for AbbVie, especially if zumilokibart becomes as successful as the company expects. In the meantime, AbbVie is still depending on its two biggest growth drivers, Skyrizi and Rinvoq, to post strong financial results. And the company boasts several other exciting pipeline candidates, including in the fast-growing weight loss market. AbbVie remains a strong buy, given all these factors, especially for dividend-seeking investors.

NEW YORK, July 19, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lucid Group, Inc. (NASDAQ: LCID) between February 25, 2026 and April 13, 2026, inclusive (the “Class Period”), of the important July 28, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Lucid securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Lucid class action, go to https://www.rosenlegal.com/cases/lucid-group-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) a supplier quality issue had significantly disrupted deliveries of the Lucid Gravity; (2) the foregoing was likely to, and did, have a material negative impact on Lucid’s business and financial results; (3) accordingly, the defendants had overstated the purported enhancements to Lucid’s manufacturing and delivery capabilities and overall operations; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Lucid class action, go to https://www.rosenlegal.com/cases/lucid-group-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

NEW YORK, July 19, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the “Class Period”), of the important July 27, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Zoetis class action, go to https://rosenlegal.com/cases/zoetis-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 27, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and touted growing market share, strong veterinarian adoption, and accelerating sales growth across Zoetis’ flagship Companion Animal products and/or failed to disclose that: (1) veterinarian prescription growth and adoption of Zoetis’ Librela, a canine pain treatment, were sharply weakening as clinicians became more cautious following FDA safety warnings concerning serious neurological complications in dogs; (2) Zoetis’ Simparica Trio was losing significant market share to a lower priced competing canine parasiticide with broader indicated use in a slowing overall market; and (3) Zoetis’ dermatology products, Apoquel and Cytopoint, were losing substantial market share to a newly launched competing canine treatment. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Zoetis class action, go to https://rosenlegal.com/cases/zoetis-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Vertex Pharmaceuticals (VRTX 0.07%) has dominated the cystic fibrosis (CF) drug market for more than a decade. This has been a very lucrative business for the biotech, and it could continue generating steady revenue and earnings from its CF products until the late 2030s, when its most important products will lose patent exclusivity. However, since it takes a long time to develop brand-new drugs, it's a good idea for Vertex Pharmaceuticals to start preparing for these patent cliffs.

Besides, there is always the possibility (however remote, considering past attempts) that another company will succeed in cracking the CF code and market competing medicines. If that happens, Vertex's shares could fall off a cliff. That's why it's important for the company to diversify its portfolio, and Vertex Pharmaceuticals recently announced an acquisition that will help it do so.

Image source: The Motley Fool.

A new acquisition could move the needle On July 6, Vertex Pharmaceuticals announced it was acquiring Crinetics Pharmaceuticals (CRNX 0.06%), a biotech focused on developing medicines for endocrine diseases, for $10 billion in cash. The buyout will grant Vertex Pharmaceuticals access to Palsonify, a medicine approved to treat acromegaly, a rare condition caused by a benign pituitary tumor that produces too much growth hormone, causing abnormal growth of bones, organs, and other tissues.

The U.S. Food and Drug Administration approved Palsonify in 2025. Beyond this marketed product, Crinetics Pharmaceuticals boasts several interesting pipeline candidates that Vertex will inherit. For instance, Crinetics is developing atumelnant, an investigational therapy for congenital adrenal hyperplasia (CAH), a group of rare genetic disorders that can be dangerous, even life-threatening, for newborns in severe cases.

Today's Change

(

-0.07

%) $

-0.36

Current Price

$

485.67

Vertex Pharmaceuticals believes that Crinetics Pharmaceuticals' Palsonify and phase 3 assets have a combined peak revenue potential of about $5 billion. That's a meaningful amount for a company that generated $12 billion in revenue last year. That's why this acquisition -- and the clinical and commercial progress Vertex could make thanks to it -- is worth keeping an eye on for investors.

Vertex Pharmaceuticals' strong outlook Vertex Pharmaceuticals has already made good progress in diversifying its lineup and pipeline. The company's approved portfolio includes Journavx, a medicine for acute pain, and Casgevy, a gene editing therapy for two rare blood-related disorders. It could also get regulatory approval for povetacicept, an investigational medicine for IgA nephropathy, by the end of November. It boasts several other pipeline programs as well and should earn additional approvals and label expansions over the next few years.

In the meantime, Vertex Pharmaceuticals' core business should continue driving strong financial results. In other words, the company's long-term prospects look increasingly strong, as it rides the success of its CF business and launches new products. The bottom line: Vertex is a top biotech stock to buy.

New York, New York--(Newsfile Corp. - July 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Verra Mobility Corporation (NASDAQ: VRRM) between February 24, 2026 and May 26, 2026, inclusive (the "Class Period"), of the important August 4, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Verra common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Verra class action, go to https://rosenlegal.com/cases/verra-mobility-corporation-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Verra's relationship with Avis Budget Group ("Avis"), and in particular obtaining a contract extension with Avis. Further, Verra minimized concerns that major rent-a-cars could replace Verra with in-house solutions or outsourced alternatives. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Verra class action, go to https://rosenlegal.com/cases/verra-mobility-corporation-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305705

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Badger Meter To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Badger Meter between April 18, 2024 and April 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - July 19, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Badger Meter, Inc. ("Badger Meter" or the "Company") (NYSE: BMI) and reminds investors of the August 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that Badger Meter's strong financial results reflected "ongoing favorable industry trends," "secular growth drivers," and "solid operating execution." They likewise touted "strong" demand and said they were seeing "robust order pacing and a strong bid pipeline that positions us well for continued sales and earnings growth," and that Badger Meter possessed a "long runway" for growth.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Badger Meter's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Badger Meter class action, go to www.faruqilaw.com/BMI or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the Badger Meter Securities Class Action Lawsuit:

What is the Badger Meter securities fraud lawsuit about?

The Badger Meter securities fraud lawsuit is a federal securities class action alleging that Badger Meter, Inc. (NYSE: BMI) and its executives made false and misleading statements to investors by touting "strong" demand, a "robust" order pipeline, and a "long runway" for growth while concealing that the Company's financial results were not sustainable. As the truth emerged through a series of disclosures - including disappointing Q2 2025 results and a sequential sales decline forecast on July 22, 2025, missed revenue expectations and a 6% sequential decline in utility water sales on January 28, 2026, and Q1 2026 earnings that missed consensus estimates by $0.26 per share with revenue missing by $28.58 million on April 17, 2026 - BMI's stock price dropped sharply, causing significant losses for investors.

Who may be eligible to participate in the Badger Meter class action lawsuit?

Investors who purchased or acquired Badger Meter (BMI) stock between April 18, 2024 and April 16, 2026 - the Class Period - and suffered financial losses may be eligible to participate in the Badger Meter securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former Badger Meter employees, and others with relevant information about the Company's conduct are also encouraged to come forward.

What is a lead plaintiff, and how can I seek appointment in the Badger Meter lawsuit?

A lead plaintiff in the Badger Meter class action is a court-appointed investor - typically the one with the largest financial interest in the case - who directs and oversees the litigation on behalf of all class members. Any Badger Meter investor who purchased BMI stock during the Class Period may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is August 3, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.

What should investors do if they purchased Badger Meter stock during the Class Period?

Investors who purchased Badger Meter (BMI) stock between April 18, 2024 and April 16, 2026 and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the Badger Meter securities class action is August 3, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/BMI for more information.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/305561

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Nuclear power is the largest source of carbon-free electricity in the United States, providing 47% of the nation's zero-emissions power and more than wind and solar combined in 2023.

Not only is nuclear power cleaner-burning, but it also provides stable baseload power, enabling power plants to run 24/7 and making the power grid more reliable and better able to handle fluctuations in energy demand throughout the day. With these attributes, it's no wonder more countries are supporting the Declaration to Triple Nuclear Energy capacity by 2050.

As the use of artificial intelligence (AI) booms and data centers grow, more companies are turning to nuclear power to meet their long-term power needs. With that in mind, here are two nuclear energy stocks that I think are excellent stocks to buy and hold for the next five years -- and beyond.

Image source: Getty Images.

Cameco is one of the world's largest uranium producers Cameco (CCJ 1.99%) owns controlling stakes in the McArthur River and Cigar Lake mines in Canada's Athabasca Basin. These are among the highest-grade mines in the world, supported by a network of roads and electricity and by fully permitted and licensed mills. They yield ore with a high uranium concentration, resulting in lower operating costs and a robust competitive advantage.

Over the next five years, Cameco has committed to delivering an average of 28 million pounds of uranium annually, enabling it to optimize inventory and prevent excess supply from flooding the market. In March, Cameco signed a massive $2.6 billion agreement with India's Department of Atomic Energy to supply 22 million pounds of uranium ore concentrate through 2035.

Today's Change

(

-1.99

%) $

-1.74

Current Price

$

85.62

In addition to supplying uranium, Cameco benefits from the build-out of nuclear energy infrastructure. That's because it has a 49% ownership stake in Westinghouse, with Brookfield Asset Management (BAM 2.50%) controlling the remaining 51%.

In June, the U.S. Department of Energy (DOE) conditionally committed $17.5 billion in loan facilities to support U.S. nuclear reactors. This funding will help finance equipment for the construction of at least 10 Westinghouse AP1000 reactors, giving Cameco upside from both construction and fuel supply for these new facilities.

Cameco has a distinct advantage with its high-grade mines in North America and its stake in Westinghouse, which should provide long-term upside for the company. This year, the stock has experienced significant volatility as investors digest the news around the nuclear energy build-out. But with Cameco down 36% from its 52-week high, I think now is an excellent time to buy the stock.

Centrus Energy domestically produces key fuels for nuclear energy Another nuclear energy stock that has undergone significant volatility in recent months is Centrus Energy (LEU +6.11%). While the stock has declined a whopping 66% from its 52-week high, the company is well positioned for the future of nuclear energy. That's because Centrus provides low-enriched uranium (LEU), the fuel used to power modern nuclear reactors.

Today's Change

(

6.11

%) $

8.98

Current Price

$

156.05

Right now, Centrus sources nuclear fuel from global suppliers, including the Russian entity TENEX. However, it is actively expanding its domestic production. That's because in 2024, following Russia's invasion of Ukraine, Congress passed the Prohibiting Russian Uranium Imports Act, banning the import of unirradiated LEU produced in Russia. To prevent reactor shutdowns, the Department of Energy (DOE) issued waivers through Jan. 1, 2028, if no viable alternatives exist.

Centrus has a waiver that allows it to import this LEU through 2027, but it is taking steps to become a domestic producer of this key fuel. To do so, the company is expanding its Piketon, Ohio, facility to produce both LEU and high-assay low-enriched uranium (HALEU), the next-generation fuel used in advanced reactors developed by companies such as Oklo and Nano Nuclear Energy.

On July 1, Centrus finalized a $900 million task order with the U.S. Department of Energy (DOE) to support nuclear fuel production and expand its Ohio facility. This is an important milestone as the company pivots from demonstrating its ability to produce HALEU to large-scale commercial production.

Investors must keep in mind that Centrus is going through a capital-intensive phase as it expands its facility, which is expected to come online in 2029 and continue expanding through the 2030s. In the meantime, it will produce HALEU in smaller quantities for private commercial customers as it expands.

Centrus Energy should benefit from strong tailwinds for LEU and HALEU fuel as nuclear energy capacity expands, making it another solid nuclear energy stock to buy and hold for the long haul.